Half-year report · HY
4552.TEDINET S100YF1R
Period2025-04-01 → 2025-09-30
Filed2026-06-23
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amends S100X3NF. Amended by S100YIE3 (2026-06-23).
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥21.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥33.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.7bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥2.4bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | −¥739m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥2.4bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥7.0bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.6bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.6bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥556m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.7bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥4.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥691m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.7bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | −¥680m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥109.0bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥104.8bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥104.6bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥60.1bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥57.1bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥48.9bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥47.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥57.0bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥15.6bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥13.2bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥15.6bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.2bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.3bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.2bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥5.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥587m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥9.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥758m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥9.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.9bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥14.32 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-36.02 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.53 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥14.31 | 2025-04-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 44.4% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.1% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 471
| Item | Context | Value | Unit |
|---|---|---|---|
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | InterimInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Notes regarding gain on sales of investment securities (text) | InterimDuration | Text · Plus | |
| Notes regarding gain on reversal of subscription rights to shares (text) | InterimDuration | Text · Plus | |
| Gain on cancellation of contract (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | InterimDuration | Original text (Japanese)当社グループは「医薬品事業」の単一セグメントであるため、記載を省略しております。 | |
| Notes revenue recognition semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |